drugset / Trial / NCT02440178

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

NCT02440178

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether prophylaxis with micafungin is effective in the induction chemotherapy for newly diagnosed acute leukemia patients.

Timeline

Start
2015-09-19
Primary completion
2017-06-01
Completion
2017-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Micafungin Peptide 50 mg Intravenous

Indications